Everest Medicines Limited

HKEX:1952.HK

33.3 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018
Operating Activities:
Net Income -844.463-247.275-1,008.719-5,658.165-214.512-991.674
Depreciation & Amortization 76.77642.77231.12420.39510.0045.117
Deferred Income Tax 0012.3932.8870.6870.155
Stock Based Compensation 73.42206.495224.98117.2714.94517.812
Change In Working Capital -81.28-29.5634.35175.90584.861-2.869
Accounts Receivables -44.644-5.165-0.04900-2.099
Inventory -7.307-11.19-0.447000
Accounts Payables 05.1650.049000
Other Working Capital 87.221-18.3734.79875.90584.861-21.27
Other Non Cash Items -84.75-1,128.193-24.0654,969.80915.358864.492
Operating Cash Flow -769.19-1,155.761-729.936-471.899-88.657-106.967
Investing Activities:
Investments In Property Plant And Equipment -265.95-432.743-975.816-519.93-93.274-211.869
Acquisitions Net 000045.909-194.456
Purchases Of Investments -3,533.293-1,160.5880000
Sales Maturities Of Investments 2,964.52500000
Other Investing Activites 6.195565.306-865.866-511.331-138.724-403.421
Investing Cash Flow 752.497-1,028.025-975.816-519.93-47.365-406.325
Financing Activities:
Debt Repayment -8.53-30.592-23.658-19.463-8.302-458.053
Common Stock Issued 29.7875.2815.8573,735.14103.317
Common Stock Repurchased 00-58.707000
Dividends Paid 000000
Other Financing Activities 21.842-25.31123.6581,922.20670.298458.053
Financing Cash Flow 10.103-25.311-76.5085,637.88461.996461.37
Other Information:
Effect Of Forex Changes On Cash 38.86559.832-58.809-270.994-3.4169.305
Net Change In Cash 32.275-2,149.265-1,841.0694,375.061-77.442-42.617
Cash At End Of Period 523.063490.7882,640.0534,481.122106.061183.503